JOURNAL OF PHARMACY AND PHARMACOLOGY, vol.69, no.8, pp.1010-1021, 2017 (SCI-Expanded)
ObjectivesWe aimed to develop lipid-polyethylene glycol (PEG)-polymer hybrid nanoparticles, which have high affinity to tumour tissue with active ingredient, a new generation antineoplastic drug, farnesylthiosalicylic acid (FTA) for treatment of glioblastoma.